Henderson Morley Remains In Talks With KMS For Sale Of ICVT
LONDON (Dow Jones)--Henderson Morley PLC (HML.LN), a biotechnology company, said Wednesday that it remains in discussions with KMS Therapeutics for the sale of ICVT, and continues to discuss with Chairman, Andrew Knight, Chief Executive, Ian Pardoe and other parties with a view to providing the comp
Read more